01 July 2005 : Case report
Is restoring regenerative potential a way to prevent anthracycline cardiotoxicity? A hypothesis.
Arnold Koller, Christian HaidMed Sci Monit 2005; 11(7): HY12-23 :: ID: 16857
Abstract
Anthracycline-induced cardiotoxic effects are a serious problem among young patients who survive childhood cancer and there is an urgent need to avoid such effects. It is generally accepted that the only effective way to do this is to prevent cardiac injury during chemotherapy. There are several possible ways to do this, though questions remain. Evidence suggests the existence of a resident population of self-renewing cardiac stem cells capable of contributing to heart repair. Cardiac stem cells have an intrinsically poor regenerative response to heart injury. However, recent results point to ways to enhance the formation of cardiac precursor cells necessary for regeneration after injury. Moreover, the results of a recent study demonstrated that activation of the Notch signaling pathway, well characterized for its role in myogenesis and tissue formation during embryogenesis, restores impaired regenerative potential of skeletal muscle by activating resident precursor cells (satellite cells), which have a markedly impaired propensity to proliferate and to produce the myoblasts necessary for muscle regeneration. Based on these findings, and because the mechanisms behind the cardiotoxic effects of anthracyclines are not fully understood and current ways to avoid anthracycline-induced cardiotoxic effects have limitations, we hypothesize herein that an attractive way to avoid these effects may be to promote repair and regeneration, as opposed to prevent injury (e.g. by dexrazoxane).
Keywords: Anthracyclines - adverse effects, Anthracyclines - therapeutic use, Heart Diseases - chemically induced, Heart Diseases - prevention & control, Myoblasts, Cardiac - drug effects, Myoblasts, Cardiac - metabolism, Myoblasts, Cardiac - physiology, Anthracyclines - therapeutic use, Antineoplastic Agents - therapeutic use, Cell Differentiation, Heart Diseases - prevention & control, Membrane Proteins - metabolism, Myoblasts, Cardiac - physiology, Myocardium - pathology, Receptors, Notch, Regeneration, Stem Cells - physiology
513 3
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
31 May 2023 : Review article
Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical Research
A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review article
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952